期刊
ONCOGENE
卷 29, 期 31, 页码 4436-4448出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2010.181
关键词
EMT; miR-661; SNAI1; StarD10; Nectin-1; breast cancer cell invasion
资金
- Fond National de la Recherche (FNR) du Luxembourg (BIOSAN)
- Fondation Luxembourgeoise Contre le Cancer
- Human Frontier Science Program [RGP0058/2005]
- INSERM
- CNRS, France
- Ministere de la Culture, de l'Enseignement Superieur et de la Recherche, Luxembourg [BFR 08/046]
- Fond National de la Recherche, Luxembourg
Epithelial to mesenchymal transition (EMT) is a key step toward metastasis. MCF7 breast cancer cells conditionally expressing the EMT master regulator SNAI1 were used to identify early expressed microRNAs (miRNAs) and their targets that may contribute to the EMT process. Potential targets of miRNAs were identified by matching lists of in silico predicted targets and of inversely expressed mRNAs. MiRNAs were ranked based on the number of predicted hits, highlighting miR-661, a miRNA with so far no reported role in EMT. MiR-661 was found required for efficient invasion of breast cancer cells by destabilizing two of its predicted mRNA targets, the cell-cell adhesion protein Nectin-1 and the lipid transferase StarD10, resulting, in turn, in the downregulation of epithelial markers. Reexpression of Nectin-1 or StarD10 lacking the 3'-untranslated region counteracted SNAI1-induced invasion. Importantly, analysis of public transcriptomic data from a cohort of 295 well-characterized breast tumor specimen revealed that expression of StarD10 is highly associated with markers of luminal subtypes whereas its loss negatively correlated with the EMT-related, basal-like subtype. Collectively, our non-a priori approach revealed a nonpredicted link between SNAI1-triggered EMT and the down-regulation of Nectin-1 and StarD10 through the up-regulation of miR-661, which may contribute to the invasion of breast cancer cells and poor disease outcome. Oncogene (2010) 29, 4436-4448; doi: 10.1038/onc.2010.181; published online 14 June 2010
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据